The National Blood Clot Alliance is pleased to welcome Gary E. Raskob, Ph.D. to its Board of Directors.
Gary Raskob is Dean of the Hudson College of Public Health, and Regents Professor of Epidemiology and Medicine, at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. His research and scholarly interests are in the prevention, diagnosis and treatment of deep-vein thrombosis and pulmonary embolism; clinical trials; prevention research; evidence-based medicine and public health; and the translation of research evidence into practice and health policy.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO). Dr. Raskob also serves as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC). He is author or co-author of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 20 articles in the New England Journal of Medicine.
Dr. Raskob is the immediate past Chair of the Board of Directors for the Association of Schools and Programs of Public Health, the organization which represents more than 100 universities in the US and globally with accredited schools and programs in public health. Dr. Raskob is active in public health service in his community, and serves as Chair of the Oklahoma City-County Board of Health, which has oversight responsibility for the health department serving the 1.3 million residents of Oklahoma City-County.
Dr. Raskob received his PhD in pharmaceutical sciences from the University of Oklahoma, a Master of Science (MSc) degree in clinical epidemiology and health research methodology from McMaster University in Hamilton, Canada, and a Bachelor of Science degree in pharmacology from the University of Toronto, Canada.
More about NBCA’s Board of Directors
